AIFF Bathi resik saben saham (EPS TTM) fireflyneuro.com

Firefly Neuroscience, Inc (AIFF) reports a TTM fundamental earnings per share metric of -0.49, driven by management's expertise in scaling the BNA AI platform. Growth is based on US IT infrastructure for brain monitoring and rising demand for neurodiagnostics. Business stability is supported by a neutral geopolitical backdrop and the medical status of the technologies, which creates a safe operating environment for the company.

The development of AI diagnostics at Firefly Neuroscience, Inc (AIFF) is reflected in the dynamics of the trailing twelve months (TTM) net income per share. This metric determines the portion of profit attributable to a single security over the last twelve months. The calculation is based on dividing the final annual financial result by the total number of shares outstanding. The stable medical status of the business minimizes geopolitical risks, making this indicator a transparent tool for assessing efficiency. An analysis of the chart's extremes warns investors against overpaying when purchasing the asset at its peak.